Last 222.00 GBp
Change Today -2.00 / -0.89%
Volume 120.1K
SLN On Other Exchanges
Symbol
Exchange
London
OTC US
Frankfurt
As of 11:35 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bertram Wiedenmann

Former Member of Scientific Advisory Board, Silence Therapeutics plc
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Bertram Wiedenmann serves as Professor of Internal Medicine, Gastroenterology and Endocrinology at the Humboldt University of Berlin. Dr. Wiedenmann serves as Chair of Hepatology and Gastroenterology & Interdisciplinary Centre of Metabolism at the Humboldt University of Berlin, Germany. Dr. Wiedenmann is a Member of Clinical Advisory Board at Shire Orphan Therapies GmbH. Dr. Wiedenmann is a member of the Medical Faculty Charité, Humboldt University, Berlin, Germany. ...

Read Full Background

Corporate Headquarters*

1 Lyric Square
London, Greater London W6 0NB

United Kingdom

Phone: 44 20 3700 9711
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLN:LN 222.00 GBp -2.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Michael French Chairman, Chief Executive Officer and President
Marina Biotech, Inc.
$127.5K
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
A$450.0K
Hans G. C. P. Schikan Chief Executive Officer and Member of Management Board
Prosensa Holding N.V.
--
Mark W. Schwartz Ph.D.Chief Executive Officer, President and Director
Galena Biopharma, Inc.
$490.0K
Mark J. Murray Ph.D.Chief Executive Officer, President and Director
Tekmira Pharmaceuticals Corporation
$377.5K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SILENCE THERAPEUTICS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.